Second People 's Hospital of Jinzhong
- World rank, all time
- #40,786 of 42,892
- Rank in China
- #3,482 of 3,536
- Research works
- 130 ▲ 10% vs 2013–17
- Citations
- 470 3.6 per fractional work
- Top-10% rate
- 19.9% record average 16.5%
- Open access
- 26% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Nursing, 5.7×. Every wedge is a field page.
- Nursing 5.7×
- Neuroscience 4.1×
- Medicine 3.0×
- Immunology and Microbiology 2.9×
- Biochemistry, Genetics and Molecular Biology 2.2×
- Dentistry 2.1×
- Pharmacology, Toxicology and Pharmaceutics 2.0×
- Psychology 1.2×
- Materials Science 0.5×
- Environmental Science 0.4×
- Health Professions 0.4×
- Engineering 0.3×
- Agricultural and Biological Sciences 0.3×
- Computer Science 0.1×
- Mathematics 0.0×
- Social Sciences 0.0×
- Economics, Econometrics and Finance 0.0×
Which keywords describe research at Second People 's Hospital of Jinzhong?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Oxidative Stress, Cardiovascular Disease, Inflammation, Obesity, Cancer, Insulin Resistance, Metabolic Syndrome and Tissue Engineering.
- Gene Expression
- Antioxidant
- Metabolic Syndrome
- Cancer
- Epidemiology
- Cardiovascular Disease
- Oxidative Stress
- Inflammation
- Obesity
- Insulin Resistance
- Tissue Engineering
- Atherosclerosis
- Mortality
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 13 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 13 words, with their numbers
- Oxidative Stress3▲ 7.1×18 topics
- Cardiovascular Disease3▲ 9.2×13 topics
- Inflammation2▲ 4.5×19 topics
- Epidemiology2▲ 1.97×25 topics
- Obesity2▲ 9.5×8 topics
- Cancer2▲ 5.3×13 topics
- Insulin Resistance2▲ 13×5 topics
- Metabolic Syndrome2▲ 6.7×8 topics
- Tissue Engineering1▲ 7.2×6 topics
- Antioxidant1▲ 5.7×6 topics
- Atherosclerosis1▲ 15×3 topics
- Gene Expression1▲ 6.8×6 topics
- Mortality1▲ 7.0×5 topics
Which research topics does Second People 's Hospital of Jinzhong publish most on?
By volume in 2022–2025: Diabetes, Cardiovascular Risks, and Lipoproteins, Ferroptosis and cancer prognosis, Dementia and Cognitive Impairment Research and Pharmacological Effects and Toxicity Studies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Diabetes, Cardiovascular Risks, and Lipoproteins Endocrinology, Diabetes and Metabolism 1 works
- 2 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 0 works
- 3 Dementia and Cognitive Impairment Research Psychiatry and Mental health 0 works
- 4 Pharmacological Effects and Toxicity Studies Pediatrics, Perinatology and Child Health 0 works
- 5 Trace Elements in Health Nutrition and Dietetics 0 works
- 6 Obstructive Sleep Apnea Research Physiology 0 works
- 7 Genetic Neurodegenerative Diseases Cellular and Molecular Neuroscience 0 works
- 8 Bone Tissue Engineering Materials Biomedical Engineering 0 works
- 9 Bone fractures and treatments Epidemiology 0 works
- 10 Prion Diseases and Protein Misfolding Molecular Biology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Second People 's Hospital of Jinzhong's research output changed?
Output in 2018–2022 was 10% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Jinzhong
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.